REVB
Revelation Biosciences Inc
NASDAQ: REVB · HEALTHCARE · BIOTECHNOLOGY
$1.12
-0.88% today
Updated 2026-05-01
Market cap
$4.32M
P/E ratio
—
P/S ratio
2.88x
EPS (TTM)
$-23.95
Dividend yield
—
52W range
$1 – $40
Volume
0.1M
Revelation Biosciences Inc (REVB) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $21.07M | $27.66M | $48.81M | $74.00M | $85.11M | $95.81M | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | +31.3% | +76.5% | +51.6% | +15.0% | +12.6% | -100.0% | — | — | — | — | — |
| Cost of revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | $69166.00 | $40008.00 | $25049.00 | $27923.00 | $27058.00 |
| Gross profit | $21.07M | $27.66M | $45.25M | $70.82M | $80.98M | $90.91M | — | $-69166.00 | $-40008.00 | $-25049.00 | $-27923.00 | $-27058.00 |
| Gross margin | 100.0% | 100.0% | 92.7% | 95.7% | 95.1% | 94.9% | — | — | — | — | — | — |
| R&D | — | — | — | — | — | — | $2561.00 | $6.91M | $5.38M | $4.15M | $3.55M | $4.06M |
| SG&A | — | $23.98M | $21.49M | $31.29M | $33.98M | $36.34M | $145492.00 | $5.04M | $5.49M | $4.51M | $4.43M | $5.01M |
| Operating income | $7.45M | $10.28M | $18.76M | $32.69M | $38.89M | $-3638.00 | $-145492.00 | $-11.95M | $-10.86M | $-8.66M | $-7.98M | $-9.07M |
| Operating margin | 35.3% | 37.2% | 38.4% | 44.2% | 45.7% | -0.0% | — | — | — | — | — | — |
| EBITDA | — | — | — | — | — | $-3638.00 | $-145492.00 | $-11.93M | $-10.84M | $-8.63M | $-7.95M | $-9.04M |
| EBITDA margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -0.0% | — | — | — | — | — | — |
| EBIT | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-175500.00 | $-145492.00 | $-11.95M | $-10.86M | $-8.66M | $-7.98M | $-9.07M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $41759.00 | $34962.00 | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $4.50M | $6.20M | $8.78M | $16.27M | $27.63M | $-3638.00 | $-136408.00 | $-11.99M | $-10.83M | $-120254.00 | $-15.04M | $-8.91M |
| Net income growth (YoY) | — | +37.7% | +41.5% | +85.4% | +69.8% | -100.0% | -3649.5% | -8687.5% | +9.7% | +98.9% | -12405.6% | +40.7% |
| Profit margin | 21.4% | 22.4% | 18.0% | 22.0% | 32.5% | -0.0% | — | — | — | — | — | — |